Categories: Wire Stories

BioDuro-Sundia Expands Drug Discovery Capacity and Capability

SHANGHAI–(BUSINESS WIRE)–BioDuro-Sundia has recently completed Discovery capability expansions of more than 100K ft2 of laboratory space within three different R&D Centers (Shanghai Waigaoqiao, Shanghai Zhangjiang, and Beijing).

Dr. Xiang Li, President of BioDuro-Sundia Drug Discovery, explains: �At BioDuro-Sundia, we are fully invested in our clientele and pro-actively planning ahead to meet their needs. A few highlights of this expansion include:

  • Discovery Biology department:
    • Enlarged HCS capability
    • Developed more than 180 new biochemical and cell assays
  • Pharmacology department added 15+ new disease models
  • Oncology department:
    • Added 40+ CDX models
    • Increased IVIS based real-time metastasis and drug distribution analyses
  • Biologics department initiated a VHH library based on:
    • Alpaca immunity, ADC, high-throughput antibody expression, affinity detection and physical and chemical characterization services
  • DMPK department added many in-vivo and in-vitro detection services.

All together, we substantially enhanced our capabilities and capacity to provide better services to our customers. We’re committed to offering both our pharma and biotech partners worldwide advanced, high-quality technical solutions for new drug discovery.”

Dr. Kent Payne, BioDuro-Sundia’s CEO, stated: “Our Discovery Team has advanced countless candidate compounds to the clinic around the world. These new expansions position us for continued growth as part of our commitment to accelerate client projects to the clinic.”

BioDuro-Sundia’s Drug Discovery platform provides end-to-end services from hit identification to lead optimization and candidate selection/profiling. Some notable technology platforms developed at BioDuro-Sundia include PROTAC, Fragment-based drug discovery (FBDD), DNA-encoded library (DEL), Nanobody, NASH models etc.

About BioDuro-Sundia

BioDuro-Sundia, an Advent International portfolio company, is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 27 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US and China with more than 3,000 employees and 10 global sites across 7 cities.

Core expertise includes small and large molecule discovery, development and scale up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Our science-driven, customer-oriented, people-focused culture enables us to provide top-tier integrated, fast, and flexible tailored services to our customers, to meet their unique needs and accelerate development timelines. For more information, please visit www.bioduro-sundia.com.

Contacts

Christina Coby

christina.coby@bioduro-sundia.com

Alex

Recent Posts

China Focus: Technology sows seeds of hope in combating desertification

HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…

9 hours ago

Novautek Honored with the “Outstanding SME ESG and Business Performance Award”

HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…

11 hours ago

V-GREEN and Xanh SM Indonesia sign MoU with Lippo for comprehensive green ecosystem in Indonesia

JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…

12 hours ago

Molex Anticipates Steady Growth in High-Speed Connectivity in 2025, Driving Electronics Design Innovations Across Diverse Industry Sectors

Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…

14 hours ago

Celebrating 25 Years of Excellence: DYXnet Embarks the New Chapter of Digital Transformation

HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…

14 hours ago

The Top 10 Best Places to Work in Egypt for 2024 revealed

CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…

16 hours ago